ACT-389949

· Idorsia Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ACT-389949, covering 2018-07-10 to 2018-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949 [Phase 1]